Artemis Medicare Services Ltd. (IN:ARTEMISMED)
:ARTEMISMED
Want to see IN:ARTEMISMED full AI Analyst Report?
ARTEMISMED Stock Chart & Stats
₹276.20
₹1.60(0.48%)
At close: 4:00 PM EST
₹276.20
₹1.60(0.48%)
Day’s Range― - ―
52-Week Range₹202.85 - ₹297.70
Previous CloseN/A
Volume93.41K
Average Volume (3M)16.54K
Market Cap
₹38.71B
Enterprise Value₹38.65B
Total Cash (Recent Filing)₹3.48B
Total Debt (Recent Filing)₹2.79B
Price to Earnings (P/E)42.3
Beta1.10
Next Earnings
May 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.16%
Share Statistics
EPS (TTM)6.30
Shares Outstanding158,306,240
10 Day Avg. Volume28,644
30 Day Avg. Volume16,535
Financial Highlights & Ratios
PEG Ratio1.06
Price to Book (P/B)5.05
Price to Sales (P/S)4.51
P/FCF Ratio80.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)₹13.16B
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue GrowthA 68% revenue increase over five years signals durable demand for Artemis's hospital services and successful geographic/service expansion. Sustained top-line growth supports scale economics, better fixed-cost absorption and long-term investment in facilities and specialty care capabilities.
Improving Profitability TrendsNet margin rising from 1% to 9% and gross margin at 24% reflect structural operational improvements: better case mix, pricing and cost control. These margin gains increase internal funding capacity and resilience, supporting sustainable earnings power if utilization and cost discipline persist.
Strong Cash Generation And FCF GrowthFCF up 44% and an OCF/Net Income ratio of 1.76 show durable operating cash conversion. Robust cash generation strengthens the company's ability to fund capex, service debt, and invest in service expansion or partnerships without relying heavily on external financing.
Bears Say
EBITDA Margins Below Industry LeadersPersistently lower EBITDA margins versus leading peers indicate structural efficiency or scale disadvantages. This can limit reinvestment capacity and pricing flexibility, making it harder to compete for high-margin specialties and to absorb cost inflation over the medium term.
Fluctuating Net Debt LevelsAlthough debt-to-equity has fallen to 0.35, periods of net debt volatility suggest episodic capex, working-capital swings or financing timing. Such volatility can strain liquidity and increase interest-cost sensitivity, reducing financial flexibility during adverse cycles.
Suboptimal Free-cash-flow ConversionA FCF-to-net-income ratio of ~0.63 shows earnings do not fully convert to free cash, limiting cash available for dividends, acquisitions or accelerated debt paydown. Improving conversion is important for durable capital allocation and to reduce reliance on external funding.
Artemis Medicare Services Ltd. News
ARTEMISMED FAQ
What was Artemis Medicare Services Ltd.’s price range in the past 12 months?
Artemis Medicare Services Ltd. lowest stock price was ₹202.85 and its highest was ₹297.70 in the past 12 months.
What is Artemis Medicare Services Ltd.’s market cap?
Artemis Medicare Services Ltd.’s market cap is ₹38.71B.
When is Artemis Medicare Services Ltd.’s upcoming earnings report date?
Artemis Medicare Services Ltd.’s upcoming earnings report date is May 30, 2026 which is in 25 days.
How were Artemis Medicare Services Ltd.’s earnings last quarter?
Artemis Medicare Services Ltd. released its earnings results on Feb 02, 2026. The company reported ₹1.603 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.603.
Is Artemis Medicare Services Ltd. overvalued?
According to Wall Street analysts Artemis Medicare Services Ltd.’s price is currently Overvalued.
Does Artemis Medicare Services Ltd. pay dividends?
Artemis Medicare Services Ltd. pays a Annually dividend of ₹0.45 which represents an annual dividend yield of 0.16%. See more information on Artemis Medicare Services Ltd. dividends here
What is Artemis Medicare Services Ltd.’s EPS estimate?
Artemis Medicare Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Artemis Medicare Services Ltd. have?
Artemis Medicare Services Ltd. has 158,306,240 shares outstanding.
What happened to Artemis Medicare Services Ltd.’s price movement after its last earnings report?
Artemis Medicare Services Ltd. reported an EPS of ₹1.603 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.214%.
Which hedge fund is a major shareholder of Artemis Medicare Services Ltd.?
Currently, no hedge funds are holding shares in IN:ARTEMISMED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Artemis Medicare Services Ltd.
Artemis Medicare Services Limited manages and operates multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a 541 bed multi-specialty hospital located in Gurugram, India. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Technical Analysis
Fortis Healthcare Ltd.
―
Indraprastha Medical Corporation Limited
―
Krishna Institute of Medical Sciences Limited
―
Metropolis Healthcare Ltd.
―
Shalby Ltd.
―